Clinical Trial Update: Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing docetaxel alone versus docetaxel combined with gemcitabine in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Docetaxel-Gemcitabine (docetaxel-gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED